Standout Papers
Citation Impact
Citing Papers
Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent
2017 Science
MYC regulates the antitumor immune response through CD47 and PD-L1
2016 Science
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
2017 Standout
Topological control of cytokine receptor signaling induces differential effects in hematopoiesis
2019 StandoutScienceNobel
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Hierarchical design of pseudosymmetric protein nanocages
2024 StandoutNatureNobel
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
2018 StandoutNobel
T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity
2017
Engineered receptors for soluble cellular communication and disease sensing
2024 StandoutNatureNobel
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory
2019
Engineering precision nanoparticles for drug delivery
2020 Standout
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Tregopathies: Monogenic diseases resulting in regulatory T-cell deficiency
2018
Top 10 Challenges in Cancer Immunotherapy
2020
A view on drug resistance in cancer
2019 StandoutNature
PD-L1–PD-1 interactions limit effector regulatory T cell populations at homeostasis and during infection
2022
Nanomaterials for T-cell cancer immunotherapy
2021
Pancreatic cancer
2020 Standout
Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells
2022 StandoutNobel
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
A compendium of proteins that interact with HIF-1α
2017 StandoutNobel
Enhanced tumor immune surveillance through neutrophil reprogramming due to Tollip deficiency
2019
Non-canonical NF-κB Antagonizes STING Sensor-Mediated DNA Sensing in Radiotherapy
2018
Hepatocellular carcinoma
2021 Standout
Cancer stem cells revisited
2017 Standout
Epigenetics in Cancer: A Hematological Perspective
2016
CXCR3 expression in regulatory T cells drives interactions with type I dendritic cells in tumors to restrict CD8+ T cell antitumor immunity
2023
Delivery technologies for cancer immunotherapy
2019 Standout
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Synthetic lethality as an engine for cancer drug target discovery
2019
Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease
2018
Next-generation regulatory T cell therapy
2019
Tumour-intrinsic resistance to immune checkpoint blockade
2019
Foxp3: a genetic foundation for regulatory T cell differentiation and function
2020 StandoutNobel
Cancer cell autophagy, reprogrammed macrophages, and remodeled vasculature in glioblastoma triggers tumor immunity
2022
Programmable synthetic receptors: the next-generation of cell and gene therapies
2024
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Mitochondrial mitophagic mechanisms of myocardial matrix metabolism and remodelling
2011
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
PROTAC targeted protein degraders: the past is prologue
2022 Standout
New function ofTSGA10gene in angiogenesis and tumor metastasis: a response to a challengeable paradox
2015
The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes
2021
Applications of machine learning in drug discovery and development
2019 Standout
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
2017 Standout
Vemurafenib resistance reprograms melanoma cells towards glutamine dependence
2015
Opportunities for Treg cell therapy for the treatment of human disease
2023 StandoutNobel
Cancer testis antigens in sarcoma: Expression, function and immunotherapeutic application
2019
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression
2018
Regulatory T-cell therapy for autoimmune and autoinflammatory diseases: The next frontier
2018
Treg cell-based therapies: challenges and perspectives
2019
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
2019 StandoutNobel
Macrophages as tools and targets in cancer therapy
2022
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
2018 Standout
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Taking regulatory T cells into medicine
2021 StandoutNobel
Regulatory T Cells and Human Disease
2020 StandoutNobel
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
2022 StandoutNobel
TIMER2.0 for analysis of tumor-infiltrating immune cells
2020 Standout
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
2023 StandoutNobel
Strategies in Developing Immunotherapy for Pancreatic Cancer: Recognizing and Correcting Multiple Immune “Defects” in the Tumor Microenvironment
2019
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
TISIDB: an integrated repository portal for tumor–immune system interactions
2019 Standout
Modular repeat protein sculpting using rigid helical junctions
2020 StandoutNobel
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Platelets subvert T cell immunity against cancer via GARP-TGFβ axis
2017
Effects of interleukin-2 in immunostimulation and immunosuppression
2019
Cancer immunotherapy using checkpoint blockade
2018 StandoutScience
Works of Giulia Parisi being referenced
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
2018 StandoutScienceNobel
Response to Programmed Cell Death-1 Blockade in a Murine Melanoma Syngeneic Model Requires Costimulation, CD4, and CD8 T Cells
2016
Antitumor activity of epigenetic immunomodulation combined with CTLA-4 blockade in syngeneic mouse models
2015
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
2017
NF-kappaB activation is associated with homocysteine-induced injury in Neuro2a cells
2008
The biology of cancer testis antigens: Putative function, regulation and therapeutic potential
2011
Anti–PD-1 Therapy in Melanoma
2015
Immunomodulatory activity of SGI-110, a 5-aza-2′-deoxycytidine-containing demethylating dinucleotide
2012
Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma
2020